Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
Strategic Plan
pCPA Revitalization
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Tezspire (tezepelumab)
pCPA File Number:
22089
Negotiation Status:
Under consideration for negotiation
Indication(s):
severe asthma
Sponsor/Manufacturer:
AstraZeneca Canada Inc.
CADTH Project Number:
SR0731
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable